Trump announces he’s nominating Dr. Erica Schwartz for CDC director

President Trump made a significant announcement on Thursday, revealing his nomination of Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC). Dr. Schwartz, a Coast Guard rear admiral who previously served as the president’s deputy surgeon general during his first term, boasts an impressive educational background with a medical degree from Brown University and a law degree from the University of Maryland.

The president took to Truth Social to express his admiration for Dr. Schwartz, referring to her as a “STAR” and praising her as “incredibly talented.” CBS News had previously reported that Dr. Schwartz was emerging as the top contender for the position, further solidifying her reputation as a leading candidate.

Currently serving as the Coast Guard’s director of health, safety, and work-life, Dr. Schwartz oversees a network of 41 clinics and 150 sick bays within the branch. Her responsibilities include implementing vaccination policies for diseases such as anthrax and smallpox, managing disaster responses, and addressing public health crises like the Ebola outbreak.

In addition to nominating Dr. Schwartz, President Trump also announced key appointments within the CDC leadership. Sean Slovenski will serve as the deputy director and chief operating officer, while Dr. Jennifer Shuford will take on the role of deputy director and chief medical officer. Dr. Sara Brenner has been appointed as the senior counselor for public health to Health and Human Services Secretary Robert F. Kennedy Jr.

The president emphasized the expertise and qualifications of these medical professionals, highlighting their knowledge, experience, and esteemed credentials. He expressed his confidence in their ability to restore the “GOLD STANDARD OF SCIENCE” at the CDC, criticizing the agency’s performance under the previous administration.

With these strategic appointments, President Trump aims to strengthen the CDC’s leadership team and enhance its capabilities in addressing public health challenges. The new appointees bring a wealth of experience and a commitment to upholding scientific standards, signaling a renewed focus on evidence-based decision-making within the agency.